about
Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?MECHANISMS IN ENDOCRINOLOGY: An update in the genetic aetiologies of combined pituitary hormone deficiencyMANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytomaThe risks of overlooking the diagnosis of secreting pituitary adenomasA pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteinsPseudotumor of the pituitary due to PROP-1 deletionMutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficienciesThe selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodelingCombined pituitary hormone deficiency: current and future status.Which patients with acromegaly are treated with pegvisomant? An overview of methodology and baseline data in ACROSTUDY.[Recent data in adrenocortical tumorigenesis].Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.Clinical, biological and genetic analysis of 8 cases of congenital isolated adrenocorticotrophic hormone (ACTH) deficiencyPituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms.Adrenal myelolipoma: an unusual cause of bilateral highly 18F-FDG-avid adrenal masses.Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients.Clinical characterization of familial isolated pituitary adenomas.R31C GNRH1 mutation and congenital hypogonadotropic hypogonadism.Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.Dose-dependent dual role of PIT-1 (POU1F1) in somatolactotroph cell proliferation and apoptosisIdentifying the Deleterious Effect of Rare LHX4 Allelic Variants, a Challenging IssueSuccessful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series.Pituitary hormone deficiencies due to transcription factor gene alterations.Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiencyPituitary stem cell update and potential implications for treating hypopituitarismPITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism.ISL1 Is Necessary for Maximal Thyrotrope Response to Hypothyroidism.The hormonal response to stress is not modified by the dramatic decrease in prolactin plasma concentration during surgery for microprolactinoma.Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.[Evaluation of vertebral bone mass in anorexia nervosa].Diagnosis and management of hyperprolactinemia: expert consensus - French Society of Endocrinology.Radiotherapy and radiosurgery in acromegaly.Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.Does first-line surgery still have its place in the treatment of acromegaly?French consensus on the management of acromegaly.Lanreotide for the treatment of acromegaly.Role of stereotactic radiosurgery in the management of pituitary adenomas.Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY.
P50
Q26770396-B8180ACC-08FA-4AA1-A2CD-3DE4B321B9D5Q26770812-05AF42F4-3E25-46AC-AAE2-64784BFA7115Q26795670-C17E7208-9AE1-49A5-85BF-C0BF3B6C8049Q28076665-289F1377-4670-4779-A7BC-291B15B18A74Q28210920-EFDFD254-3534-43F8-974F-B94803E44B22Q28217112-BBFEB5E2-18EC-4B7D-B101-99BBC6CA64B2Q28254194-3DDE13E4-CE1C-40CE-B547-220F2C048115Q28511535-6C55CAB9-076C-49C9-8BF6-0518ABE4DDF6Q30848681-3AEA8B6A-A962-4450-A96E-F6F9E5E72224Q33493800-05B68DCB-FAEF-40DF-AE10-AD1FF6ADD5D8Q33514162-56C32C7E-7039-4B26-85AC-25C78E616AF4Q33531990-996C116E-AAB2-445E-91FE-CB97E4A21C64Q33862265-B511A24A-FD9B-4300-B83C-BA70F9AE4B2AQ34017922-30209CFA-E4A1-4019-B4E0-A124B4660A76Q34058630-59B164E3-EA4A-4592-B6D9-E96B0ECF9E35Q34160940-AD368E83-2726-4918-BD04-B4086BCE9267Q34279288-694505F9-B905-4D2E-9F52-33204E1BE6AFQ34323918-A543038E-E05B-40BE-BAA8-B467C6B5F687Q34540360-9B845AD9-5387-4E21-B708-D1734B063FF7Q34920649-D367757D-E415-4610-804E-51137F24BDE8Q35105992-B5762B99-C4C6-4F14-B743-0DF8A0CD6FA5Q35231490-EB8FA164-37A4-443D-943B-DC1E30DABB9FQ35587203-6082E594-352E-4602-8E17-F4D7837FCECEQ35670474-1752593D-ABAB-4036-A359-4F062EE8B653Q35935325-70508E3F-8BAC-44ED-BA1A-2A1000676B9AQ35964450-3FEFAF3E-8728-40CF-9ADA-6A8111CBBB35Q36014901-A84AA068-A3B7-4CEE-BBBC-4331DD0D74CEQ36067458-EFF2EE34-BF93-4410-AB18-D70479185827Q36107279-B483BE51-FBBB-4C0D-B070-390A38C4422AQ36318796-860CDD2B-42F5-4AA8-8EC2-DB573FB63097Q36335109-42B5C6C7-7E5F-4596-B3EE-078610A5C215Q36715948-7C59926C-5423-4DA6-8CAA-F9779940D448Q36742772-F2EF7D9F-78E9-4502-AF15-0964499757FDQ37050494-E7E33F24-2D2C-4ECB-9496-0ED1B2377F94Q37074528-146DCC8D-84E5-4D25-98BD-D685FA5C88F4Q37432869-24DE7FFF-E333-4D89-B7A9-6D6AA916F52EQ37433109-2ED3D795-E15B-4D45-A784-05421FE6133EQ37521920-747971D4-A3AB-4447-B5EF-4B5DD47035E4Q37696963-19B3CA96-E39F-41CB-B6AA-17B2460F1C18Q37987886-F97FE295-8B1A-46AD-92D3-4FA7FDA0940B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thierry Brue
@ast
Thierry Brue
@en
Thierry Brue
@es
Thierry Brue
@nl
Thierry Brue
@sl
type
label
Thierry Brue
@ast
Thierry Brue
@en
Thierry Brue
@es
Thierry Brue
@nl
Thierry Brue
@sl
prefLabel
Thierry Brue
@ast
Thierry Brue
@en
Thierry Brue
@es
Thierry Brue
@nl
Thierry Brue
@sl
P106
P21
P31
P496
0000-0001-8482-6691